Research has confirmed that various inflammatory biomarkers—including high-sensitivity C-reactive protein (hs-CRP), systemic inflammatory response index (SIRI), and monocyte to high-density lipoprotein cholesterol ratio (MHR)—positively correlate with hyperuricemia (7–9). This evidence concerns the gene CRP and hyperuricemia.